Up a level |
(2020) Resveratrol as an adjuvant for normal tissues protection and tumor sensitization. Current Cancer Drug Targets.
(2019) Intercellular communications-redox interactions in radiation toxicity; potential targets for radiation mitigation. Journal of Cell Communication and Signaling.
(2019) Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization. Clinical and Translational Oncology.
(2019) Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization. Clinical and Translational Oncology.
(2019) Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization. Clinical and Translational Oncology.
(2019) Metformin as a Radiation Modifier; Implications to Normal Tissue Protection and Tumor Sensitization. Current clinical pharmacology.
(2019) Metformin as a Radiation Modifier; Implications to Normal Tissue Protection and Tumor Sensitization. Current clinical pharmacology.
(2019) NADPH oxidase as a target for modulation of radiation response; implications to carcinogenesis and radiotherapy. Current Molecular Pharmacology.